Segments - Europe Fluoroscopy Market by Device Types (Fixed Fluoroscopy and Mobile Fluoroscopy [Mini Fluoroscopes and Full-size Fluoroscopes]), Applications (Urology, Neurology, Orthopedic, Gastrointestinal, Cardiovascular, General Surgery, Pain Management and Trauma, and Other Applications), and Geography (United Kingdom, Spain, France, Germany, Italy, and Rest of Europe) - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
The Europe fluoroscopy market size was USD 2.12 Billion in 2022 and is likely to reach USD 2.81 Billion by 2031, expanding at a CAGR of 3.2% during 2023–2031. The growth of the market is attributed to rising use of fluoroscopy in pain management and increasing demand for minimally-invasive surgeries, prevalence of chronic diseases, and rising geriatric population.
Fluoroscopy is a type of medical imaging that gives continuous x-ray image on a monitor. Medical imaging is widely used in patient management processes including therapy delivery, staging, diagnosis, and follow ups.
Fluoroscopy is used in examinations and procedures to treat or diagnose patients such as stents, catheter insertion and manipulation, angiograms, orthopedic surgery, and barium x-rays & enemas. A typical fluoroscope has four components such as x-ray source, x-ray image intensifier, imaging system, and a work station.
Fluoroscopy helps in locating image-guided anesthetic injections, foreign bodies, and percutaneous vertebroplasty. fluoroscopy has low risk to the patients and reduces the hospital stay period.
The market is growing as the demand for infrastructure development in hospitals and healthcare industry is rising. Fluoroscopy is not used only in early diagnosis of chronic diseases but it is also used in appropriate and swift guidance during corrective and treatment procedures.
Growing number of minimally invasive surgeries that are of high-precision is estimated to spur the market in the coming years.
Usage of fluoroscopy in pain management is anticipated to boost the market during the forecast period.
Rapid growth of the hospitality industry is the main factor driving the market in the coming years.
Radiation risk from exposure to x-ray images act as key factor that can hinder the market.
Lack of awareness of innovative application and shortage of medical professionals can hamper the market growth.
Innovation in the technologies is projected to create significant opportunities for the market players.
R&D investment and technological advancement in the fluoroscopy market is expected to offer immense opportunities for the market players.
The report on the Europe fluoroscopy market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Fluoroscopy Market - Europe Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2022 |
Historic Data |
2016–2021 |
Forecast Period |
2023–2031 |
Segmentation |
Device Types (Fixed Fluoroscopy and Mobile Fluoroscopy [Mini Fluoroscopes and Full-size Fluoroscopes]), Applications (Urology, Neurology, Orthopedic, Gastrointestinal, Cardiovascular, General Surgery, Pain Management and Trauma, and Other Applications) |
Geographical Scope |
United Kingdom, Spain, France, Germany, Italy, and Rest of Europe |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report |
Siemens Healthcare Private Limited, Hitachi Medical Systems, GE Healthcare, Canon Medical System Corporation, and Koninklijke Philips NV |
Based on device types, the Europe fluoroscopy market is bifurcated into fixed fluoroscopy and mobile fluoroscopy. Mobile fluoroscopy is further segmented into mini fluoroscopes and full-size fluoroscopes.
The fixed fluoroscopy segment is expected to represent a key share of the market during the forecast period owing to increasing demand as it is used in designated rooms for studies including endoscopy of the gastrointestinal, catheterization of blood vessels, and barium studies.
On the basis of applications, the Europe fluoroscopy market is segregated into urology, neurology, orthopedic, gastrointestinal, cardiovascular, general surgery, pain management and trauma, and other applications. The cardiovascular segment is expected to constitute a key share of the market in the coming years due to increase in the prevalence of cardiovascular diseases around the world.
Fluoroscopy is highly used in pain management and treating the patients. Cardiovascular process includes comprehensive fluoroscopic advice to navigate endovascular catheters. However, the orthopedic segment is anticipated to expand at a rapid pace during the forecast period owing to rise in orthopedic disorders globally.
On the basis of regions, the Europe fluoroscopy market is categorized as United Kingdom, Spain, France, Germany, Italy, and Rest of Europe. The market of United Kingdom is anticipated to expand at a healthy CAGR during the forecast period.
The regional market growth can be attributed to the increasing population, healthcare reforms and government investments & initiatives in country. Many key players are developing products for clinical applications.
The Europe fluoroscopy market has been segmented on the basis of
Key players competing in the Europe Fluoroscopy market include Siemens Healthcare Private Limited, Hitachi Medical Systems, GE Healthcare, Canon Medical System Corporation, and Koninklijke Philips NV. Some of these players are focusing on several market strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase their market shares.